Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Rhovac board member resigns due to health reasons 2022-10-18 21:29
Alphyn Biologics Announces Enrollment Passes Halfway Point in Phase2a Clinical Trial of Mild-to-Moderate Atopic Dermatitis Treatment 2022-10-18 19:30
CSafe Continues Expansion of Its Temperature-Controlled Shipping Solutions Portfolio with Introduction of Advanced Reusable Pallet Shipper 2022-10-18 19:00
TLX250-CDx Indication Expansion: Preliminary Data Presented at EANM 2022-10-18 06:43
Kira Pharmaceuticals to Present First-in-Human Clinical Data at American Society for Nephrology Kidney Week 2022 2022-10-17 19:00
Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market 2022-10-17 13:00
Innovent Announces Phase Ib Results of Higher-dose Mazdutide (IBI362) in Chinese Participants with Overweight or Obesity Published in eClinicalMedicine 2022-10-17 08:00
Kira Pharmaceuticals Announces IND Approval from Chinese NMPA for Phase 2 Evaluation of KP104 in Paroxysmal Nocturnal Hemoglobinuria (PNH) 2022-10-17 07:31
Chinese NMPA Approves Pivotal Phase III Study of TLX591-CDx for Prostate Cancer Imaging 2022-10-17 07:25
Transcenta to Present Two Scientific Posters at SITC 2022 Annual Meeting 2022-10-14 08:00
Alex Therapeutics presents results from digital therapeutic pilot study showing nearly 50% reduction in anxiety 2022-10-13 14:39
Jacobio Pharma to Collaborate with Merck on Clinical Trial of JAB-21822 in Combination with Cetuximab 2022-10-13 09:00
RemeGen Receives Orphan Drug Designation from FDA for Telitacicept for the Treatment of Myasthenia Gravis 2022-10-13 08:00
Dr Ivan Puah, Liposuction Doctor In Singapore, Shares The Secret To Achieving A Good Liposuction Result 2022-10-12 11:38
WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody 2022-10-12 09:00
CSafe and BioLife Solutions, Inc. announce partnership to expand supply chain solutions for the cell and gene therapy market 2022-10-11 22:10
Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib 2022-10-11 13:00
JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in Patients with Relapsed or Refractory Follicular Lymphoma 2022-10-10 20:00
Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets 2022-10-10 15:00
The China NMPA Approves Selpercatinib for the Treatment of Patients with RET-driven Lung and Thyroid Cancers 2022-10-10 08:23
1 59 60 61 62 63 230